Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

Nasdaq Down Over 100 Points; Sidus Space Shares Spike Higher

Published 03/01/2024, 19:20
Updated 03/01/2024, 20:40
© Reuters.  Nasdaq Down Over 100 Points; Sidus Space Shares Spike Higher
GC
-
HG
-
SI
-
CL
-
IXIC
-
ESPR
-
SASI
-
SOFI
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 100 points on Wednesday.

The Dow traded down 0.52% to 37,518.35 while the NASDAQ fell 0.98% to 14,621.38. The S&P 500 also fell, dropping, 0.61% to 4,713.82.

Check This Out: How To Earn $500 A Month From Apple Stock Following Tuesday's Slide

Leading and Lagging Sectors

Energy shares rose by 0.8% on Wednesday.

In trading on Wednesday, real estate shares fell by 1.8%.

Top Headline

The number of job openings fell by 62,000 from the prior month to 8.790 million in November, compared to market estimates of 8.85 million.

Equities Trading UP

Sidus Space, Inc. (NASDAQ: SIDU) shares shot up 62% to $11.32 after it secured a Tier 1 remote sensing license to include Panchromatic (PAN) and Shortwave Infrared (SWIR) imaging capabilities.

Shares of Trinity Place Holdings Inc. (NYSE: TPHS) got a boost, surging 55% to $0.1774. The company reported in 8K Filing, mortgage lender agreed to extend the mortgage loan forbearance period to Jan. 31, 2024.

Sigma Additive Solutions, Inc. (NASDAQ: SASI) shares were also up, gaining 47% to $4.2609. Sigma Additive Solutions, announced in an 8-K Filing, the approval of the issuance of the shares of common stock in exchange for all the capital stock of NextTrip Holdings.

Equities Trading DOWN

SoFi Technologies, Inc. (NASDAQ: SOFI) shares dropped 14% to $8.32 after Keefe, Bruyette & Woods downgraded rating on the stock from Market Perform to Underperform and lowered the price target from $7.50 to $6.50.

Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) were down 21% to $2.2950 after the company announced a $125 million amendment to the collaboration with Japanese pharma company Daiichi Sankyo Co., Ltd.

Nemaura Medical Inc. (NASDAQ: NMRD) was down, falling 30% to $0.1317. Nemaura Medical's board of directors and management team have made the strategic decision to accept Nasdaq's determination to delist Nemaura Medical and move to the OTC Markets.

Also Check This Out: Top 3 Industrials Stocks That Could Blast Off In Q1

Commodities

In commodity news, oil traded up 3.3% to $72.72 while gold traded down 1.6% at $2,040.20.

Silver traded down 3.5% to $23.125 on Wednesday while copper fell 0.4% to $3.8635.

Euro zone

European shares closed lower today. The eurozone’s STOXX 600 fell 0.86%, London’s FTSE 100 fell 0.51% while Spain’s IBEX 35 Index fell 1.26% The German DAX fell 1.38% French CAC 40 fell 1.58% while Italy’s FTSE MIB Index dipped 1.39%.

German jobless rate rose to 5.9% in December from November's revised reading of 5.8%. The number of people registering as jobless in Spain fell by 1%, reaching 2.71 million for December.

Asia Pacific Markets

Asian markets closed mostly lower on Wednesday, with Hong Kong’s Hang Seng Index falling 0.85% and China’s Shanghai Composite Index gaining 0.17%. India’s S&P BSE Sensex, meanwhile, fell 0.75%.

The S&P Global Indian manufacturing PMI fell to 54.9 in December from 56.0 in the prior month. Australian CoreLogic Home Value Index increased 0.4% in December versus a 0.6% increase a month ago.

Economics

Mortgage applications in the U.S. declined by 10.7% in the week ending Dec. 29.

The number of job openings fell by 62,000 from the prior month to 8.790 million in November, compared to market estimates of 8.85 million.

The ISM Manufacturing PMI rose to 47.4 in December from 46.7 in the prior month, and topping than market estimates of 47.1. However, the recent reading signalled contraction in factory activity for the 14th month.

Now Read This: Jim Cramer Says Move On From This Energy Stock: 'It's Moved Too Much'

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.